CytoMed Therapeutics Ltd(GDTC)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

CytoMed Therapeutics Ltd (GDTC) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. GDTC is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.3m in revenue and is scored on the micro-cap board instead. Top institutional holders of GDTC by reported 13-F value include Axiom Investment Management, UBS Group AG, OSAIC, based on the most recent SEC filings. GDTC trades on the Nasdaq exchange and files with the SEC under CIK 1873093. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GDTC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CytoMed Therapeutics Ltd directly from SEC EDGAR.

GDTC key financials by period

CytoMed Therapeutics Ltd reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202520-F$324.4K——
FY 202420-F$69.5K——

Institutions holding GDTC

Institutional investors reporting a position in CytoMed Therapeutics Ltd on SEC Form 13F.
InstitutionSharesValueReported
Axiom Investment Management7,032$7.2K2026-06-30
UBS Group AG4,831$5.0K2026-06-30
OSAIC21$21.002026-06-30
SEC EDGAR: CIK 1873093 →
GDTC

CytoMed Therapeutics Ltd

GDTC
NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.3M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Financial metrics will appear once SEC EDGAR data is ingested for this company.

Top Institutional Holders

as of Q2 2026
$12.2K total
Axiom Investment Management LLC
$7.2KNew
UBS Group AG
$5.0K-21.9%
OSAIC HOLDINGS, INC.
$210.0%
Loading ratio trend…